Treatment of the Early Manifestations of Lyme Disease
- ALLEN C. STEERE, M.D.;
- GORDON J. HUTCHINSON, M.D.;
- DANIEL W. RAHN, M.D.;
- LEONARD H. SIGAL, M.D.;
- JOSEPH E. CRAFT, M.D.;
- ELISE T. DeSANNA, B.A.; and
- STEPHEN E. MALAWISTA, M.D.
Abstract
During 1980 and 1981, we compared antibiotic regimens in 108 adult patients with early Lyme disease. Erythema chronicum migrans and its associated symptoms resolved faster in penicillin- or tetracycline-treated patients than in those given erythromycin (mean duration, 5.4 and 5.7 versus 9.2 days, F = 3.38, p < 0.05). None of 39 patients given tetracycline developed major late complications (meningoencephalitis, myocarditis, or recurrent attacks of arthritis) compared with 3 of 40 penicillin-treated patients and 4 of 29 given erythromycin (chi square with 2 degrees of freedom = 5.33, p = 0.07). In 1982, all 49 adult patients were given tetracycline; again, none of them developed major complications. However, with all three antibiotic agents nearly half of the patients had minor late symptoms such as headache, musculoskeletal pain, and lethargy. These complications correlated significantly with the initial severity of illness. For patients with early Lyme disease, tetracycline appears to be the most effective drug, then penicillin, and finally erythromycin.
Article and Author Information
-
▸From the Department of Internal Medicine, Yale University School of Medicine; New Haven, Connecticut.
-
Grant support: in part by U. S. Public Health Service Grants AM-20358, AM-07107, AM-5639, and RR-00125, and the Arthritis Foundation and its Connecticut chapter.
-
▸Requests for reprints should be addressed to Allen C. Steere, M.D.; Department of Internal Medicine, Yale University School of Medicine, 333 Cedar Street; New Haven, CT 06510.
- © 1983 American College of Physicians
RSS Feeds









